| Literature DB >> 22261332 |
Zhenqiang You1, Yanfei Xin1, Yan Liu2, Junying Sun3, Guoliang Zhou1, Haiyan Gao1, Pansheng Xu1, Yunxiang Chen1, Guochan Chen1, Lijiang Zhang1, Liqiang Gu1, Zhiqin Chen1, Bin Han1, Yaoxian Xuan4.
Abstract
Renal cell carcinoma (RCC) is a highly malignant and often fatal disease of the kidney. Chmp1A is a member of the Endosomal Sorting Complex Required for Transport (ESCRT-III) family, and plays a role in the cytoplasm in sorting proteins to the multivesicular body (MVB). Chmp1A functions as a tumor suppressor gene and has been reported in pancreatic tumor cells. Here, we examined the expression level of Chmp1A in human RCC tissues and renal tumor cells by real-time quantitative RT-PCR and western blot. We found that the expression level of Chmp1A is significantly lower in RCC tissues and renal tumor cells compared with adjacent non-tumorous tissues and normal renal cells. Additionally, inhibition of Chmp1A expression by shRNA induced tumor formation in normal renal cells. However, inhibition of Chmp1A did not significantly affect tumor cell proliferation in vitro and tumor progression in vivo. Interestingly, overexpression of Chmp1A using a eukaryotic plasmid inhibited the proliferation of renal tumor cells in vitro and the growth of renal tumor in vivo. Thus, our results demonstrate that Chmp1A functions as a tumor suppressor gene in renal cells and may be a useful target for treatment of RCC.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22261332 DOI: 10.1016/j.canlet.2012.01.010
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679